Loading…
Import this data to Google Sheets with:
=jivedata("BZAIW","financials")Full statements spill as a table. For one cell: =jivedata("BZAIW","Revenue") or =jivedata("BZAIW","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
BZAIW • CIK 0001871638
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax | — | — | $38,632 | $50,366 |
| Cost of Revenue | — | — | $32,438 | $43,536 |
| Gross Profit | — | — | $6,194 | $6,830 |
| Operating Income (Loss) | $-3,384.81 | $-4,976.528 | $-103,841 | $-97,929 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $2,366.786 | $-3,596.353 | $-206,687 | $-80,633 |
| Income Tax Expense (Benefit) | $1,027.644 | $517.179 | $217 | $383 |
| Net Income (Loss) Attributable to Parent | $1,339.142 | $-4,113.532 | $-206,904 | $-81,016 |
| Weighted Average Number of Shares Outstanding, Basic | — | — | 104,275,265 | 134,527,679 |
| Research and Development Expense | — | — | $42,523 | $39,947 |
| Depreciation, Nonproduction | — | — | $1,195 | $953 |
| Operating Expenses | — | — | $110,035 | $104,759 |
| Gain (Loss) on Derivative Instruments, Net, Pretax | — | — | $117,113 | $9,983 |
| Fair Value Adjustment of Warrants | — | — | $-4,125 | $-67,283 |
| Other Nonoperating Income (Expense) | — | — | $992 | $1,006 |
| Nonoperating Income (Expense) | $5,751.596 | $1,380.175 | $-102,846 | $17,296 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Property, Plant and Equipment, Net | — | — | $1,226 | $1,401 |
| Deferred Income Tax Assets, Net | — | — | $2,123 | $2,036 |
| Operating Lease, Right-of-Use Asset | — | — | $1,516 | $1,307 |
| Other Assets, Noncurrent | — | — | $739 | $2,093 |
| Assets | $72,594.378 | $48,316.954 | $102,211 | $79,514 |
| Operating Lease, Liability, Noncurrent | — | — | $804 | $640 |
| Derivative Liability, Noncurrent | — | — | $8,929 | $6,827 |
| Other Liabilities, Noncurrent | — | — | $1,276 | $2,024 |
| Liabilities | $41,441.175 | $24,079.688 | $63,211 | $36,724 |
| Cash and Cash Equivalents, at Carrying Value | $22.232 | $1.506 | $45,781 | $36,847 |
| Inventory, Net | — | — | $10,130 | $10,027 |
| Prepaid Expense and Other Assets, Current | — | — | $4,003 | $12,858 |
| Assets, Current | $25,701.203 | $758.842 | $96,607 | $73,984 |
| Accounts Payable, Trade, Current | — | — | $22,838 | $1,528 |
| Accrued Liabilities, Current | $2,123.846 | $4,882.163 | $6,700 | $9,988 |
| Operating Lease, Liability, Current | — | — | $644 | $596 |
| Liabilities, Current | $31,378.675 | $14,017.188 | $43,389 | $19,904 |
| Common Stock, Value, Issued | — | — | $12 | $14 |
| Additional Paid in Capital | — | $0 | $675,143 | $729,903 |
| Retained Earnings (Accumulated Deficit) | $-15,839.811 | $-23,362.085 | $-636,155 | $-687,617 |
| Stockholders' Equity Attributable to Parent | $-15,838.729 | $-23,361.003 | $39,000 | $42,790 |
| Common Stock, Shares Authorized | — | — | 600,000,000 | 600,000,000 |
| Common Stock, Shares, Issued | — | — | 122,043,966 | 142,778,075 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations | — | — | $-4,438 | $8,250 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $843.313 | $758.842 | $46,050 | $34,307 |
| Net Income (Loss) Attributable to Parent | $1,339.142 | $-4,113.532 | $-206,904 | $-81,016 |
| Net Cash Provided by (Used in) Operating Activities | $-2,335.341 | $-2,770.927 | $-73,751 | $-82,675 |
| Payments to Acquire Property, Plant, and Equipment | — | — | $788 | $746 |
| Net Cash Provided by (Used in) Investing Activities | $230,122.112 | $1,800.201 | $-788 | $-746 |
| Proceeds from Issuance of Private Placement | — | — | $27,902 | $27,902 |
| Payment of Financing and Stock Issuance Costs | — | — | $7,658 | $3,326 |
| Proceeds from Issuance of Common Stock | — | — | $33,250 | $66,075 |
| Proceeds from Stock Options Exercised | — | — | $345 | $792 |
| Proceeds from Convertible Debt | — | $689.655 | $0 | $0 |
| Net Cash Provided by (Used in) Financing Activities | $-226,965.69 | $886.255 | $70,101 | $91,302 |
| Cash and Cash Equivalents, at Carrying Value | $22.232 | $1.506 | $45,781 | $34,033 |
| Restricted Cash and Cash Equivalents | — | — | $269 | $274 |
| Income Taxes Paid, Net | $791.758 | $1,027.644 | $337 | $337 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | — | $0 | $0 |
| Debt Conversion, Converted Instrument, Amount | — | — | $314,331 | $-3 |
| Conversion of Stock, Amount Converted | — | — | $75,056 | $0 |
| Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | — | — | $431 | $660 |
| Depreciation, Nonproduction | — | — | $1,195 | $953 |
| Operating Lease, Right-of-Use Asset, Amortization Expense | — | — | $688 | $688 |
| Share-based Payment Arrangement, Noncash Expense | — | — | $37,546 | $37,546 |
| Accounts Receivable, Credit Loss Expense (Reversal) | — | — | $557 | $557 |
| Deferred Income Tax Expense (Benefit) | — | — | $-368 | $-368 |
| Fair Value Adjustment of Warrants | — | — | $-4,125 | $-67,283 |
| Gain (Loss) on Derivative Instruments, Net, Pretax | — | — | $117,113 | $9,983 |
| Increase (Decrease) in Inventories | — | — | $1,569 | $1,569 |
| Increase (Decrease) in Prepaid Expense and Other Assets | — | $-186.532 | — | — |
| Increase (Decrease) in Accounts Payable, Trade | — | — | $22,838 | $22,838 |
| IncreaseDecreaseInOperatingLeaseLiability | — | — | $-727 | $-727 |
| Increase (Decrease) in Other Current Liabilities | — | — | $-360 | $-360 |